Financial Council’s AbbVie ABBV Stock Holding History

Financial Council’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.29M	Sell	5,951 -45	-0.8%	-$9.98K	0.5%	31
2025 Q4	$1.37M	Sell	5,996 -12	-0.2%	-$2.73K	0.55%	31
2025 Q3	$1.39M	Buy	6,008 +124	+2%	+$25.3K	0.62%	31
2025 Q2	$1.09M	Hold	5,884	–	–	0.53%	31
2025 Q1	$1.23M	Hold	5,884	–	–	0.66%	29
2024 Q4	$1.05M	Hold	5,884	–	–	0.54%	31
2024 Q3	$1.16M	Hold	5,884	–	–	0.61%	29
2024 Q2	$1.01M	Hold	5,884	–	–	0.56%	33
2024 Q1	$1.07M	Hold	5,884	–	–	0.63%	29
2023 Q4	$912K	Hold	5,884	–	–	0.61%	30
2023 Q3	$877K	Hold	5,884	–	–	0.7%	22
2023 Q2	$793K	Sell	5,884 -125	-2%	-$18.3K	0.61%	27
2023 Q1	$958K	Hold	6,009	–	–	0.78%	22
2022 Q4	$971K	Hold	6,009	–	–	0.61%	25
2022 Q3	$806K	Buy	6,009 +1,172	+24%	+$168K	0.93%	21
2022 Q2	$741K	Hold	4,837	–	–	0.92%	25
2022 Q1	$784K	Buy	4,837 +1,133	+31%	+$165K	0.95%	23
2021 Q4	$502K	Buy	3,704 +9	+0.2%	+$1.06K	0.6%	26
2021 Q3	$399K	Buy	+3,695	New	+$422K	0.56%	28

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Council's ABBV Position: Q1 2026 in Review

Financial Council reduced its AbbVie (ABBV) stake by 0.75% in Q1 2026, selling an estimated $9.98K and leaving 5,951 shares worth $1.29M. The position accounts for 0.5% of the portfolio, ranked #31.

Financial Council first reported a position in ABBV in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.39M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Financial Council held 5,951 shares of AbbVie worth $1.29M as of Q1 2026.
Financial Council sold 45 AbbVie shares in Q1 2026, an estimated $9.98K.
AbbVie made up 0.5% of Financial Council's portfolio in Q1 2026, its #31 holding.
Financial Council first reported a position in AbbVie in Q3 2021 and has held it in 19 quarters since.
Financial Council's AbbVie position peaked at $1.39M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Financial Council's 13F filing for Q1 2026, filed 21 Apr 2026.